Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Core EBITDA Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 1.8512.5759.64-14.83-17.62

What is the latest Core EBITDA Growth ratio of AUROBINDO PHARMA ?

The latest Core EBITDA Growth ratio of AUROBINDO PHARMA is 1.85 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar20261.85
Mar202512.57
Mar202459.64
Mar2023-14.83
Mar2022-17.62

How is Core EBITDA Growth of AUROBINDO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2026 1.85
-85.28
Mar2025 12.57
-78.92
Mar2024 59.64
Positive
Mar2023 -14.83
Negative
Mar2022 -17.62 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Core EBITDA Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹97,990.6 Cr 0.2% 4.2% 53.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr -0.2% -3.2% 12.7% Stock Analytics
DIVIS LABORATORIES ₹251,531.0 Cr 2% 5.3% 57.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,957.0 Cr -2.4% -3.1% 36.4% Stock Analytics
CIPLA ₹111,729.0 Cr 0.6% -2.2% -9.4% Stock Analytics
DR REDDYS LABORATORIES ₹104,335.0 Cr 0.9% 4% -7.6% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.2%

4.2%

53.1%

SENSEX

-2.7%

-5.7%

-11.7%


You may also like the below Video Courses